Study guide

4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders

Key Takeaways Explain This Topic AI

Painless bright red bleeding with a soft uterus suggests placenta previa, painful dark bleeding with a rigid tender uterus suggests abruption, and painless bleeding at membrane rupture with fetal bradycardia or a sinusoidal pattern suggests vasa previa.

Digital cervical examination is absolutely contraindicated in third-trimester bleeding until ultrasound has excluded placenta previa.

Ultrasound is negative in about half of placental abruptions, so abruption remains a clinical diagnosis and imaging must never delay delivery.

Polyhydramnios is an amniotic fluid index of 24 cm or more or a deepest vertical pocket of 8 cm or more; oligohydramnios is an index below 5 cm or a pocket below 2 cm.

Prenatally diagnosed vasa previa is delivered by planned cesarean at 34 0/7 to 37 0/7 weeks, and amniotomy is never performed.

Last updated: September 2026

Third-Trimester Vaginal Bleeding Differential

Vaginal bleeding in the late second or third trimester is a life-threatening obstetric emergency until proven otherwise. Immediate assessment must prioritize maternal hemodynamic stability and fetal oxygenation while identifying the etiology.

Clinical Characteristic Placenta Previa Placental Abruption (Abruptio Placentae) Vasa Previa

Underlying Anatomy Placenta overlies or is adjacent to internal cervical os Premature detachment of a normally implanted placenta Fetal vessels course through membranes over the internal os

Nature of Bleeding Painless , bright red vaginal bleeding Painful , dark red vaginal bleeding (20% concealed) Painless vaginal bleeding occurring at membrane rupture

Uterine Tone & Contractions Uterus is soft, nontender, and relaxed; no tachysystole Uterus is firm, board-like, exquisitely tender; high-frequency contractions Uterine tone is normal; no tenderness or hypertonus

Fetal Heart Rate (FHR) Usually reassuring initially unless massive maternal shock Variable decelerations, late decelerations, bradycardia, loss of variability Catastrophic fetal bradycardia or sinusoidal FHR pattern

Primary Risk Factors Prior cesarean birth, prior previa, multiparity, advanced maternal age, smoking Chronic hypertension, preeclampsia, cocaine use, trauma, sudden uterine decompression Velamentous cord insertion, bilobed/succenturiate placenta, in vitro fertilization

Diagnostic Standard Transvaginal ultrasound (safe and highly accurate) Clinical diagnosis; ultrasound is negative in 50% (does not rule out abruption) Color Doppler transvaginal ultrasound showing pulsating vessels

Mandatory Contraindication Strictly NEVER perform a digital vaginal exam until previa is excluded Do not delay emergency delivery for ultrasound confirmation Never perform artificial rupture of membranes (AROM)

Placenta Previa

Classification: Complete (placental tissue completely covers the internal os) or Marginal (placental edge lies within 2 cm of the internal os). If the edge is >2 cm from the os in the lower uterine segment, it is termed a low-lying placenta.

Digital Examination Precaution: Digital cervical examination can tear placental cotyledons from the lower uterine segment, inducing catastrophic maternal exsanguination. Ultrasound confirmation of placental location is mandatory prior to any digital exam in bleeding patients.

Delivery Timing: Stable patients with persistent complete placenta previa undergo planned cesarean delivery between 36 0/7 and 37 6/7 weeks gestation to avoid the onset of unscheduled labor and severe hemorrhage.

Placental Abruption

Pathophysiology: Rupture of maternal spiral arterioles in the decidua basalis produces a retroplacental hematoma that shears the placenta from the uterine wall. Impaired gas exchange leads to acute fetal hypoxemia and acidemia.

Clinical Spectrum: May be revealed (external vaginal bleeding) or concealed (blood remains trapped behind the placenta; uterine fundal height increases). The release of tissue thromboplastin into the maternal circulation frequently triggers rapid-onset disseminated intravascular coagulation (DIC) characterized by hypofibrinogenemia (<200 mg/dL), thrombocytopenia, and elevated D-dimer.

Management: Large-bore IV access (two 16-gauge catheters), blood bank crossmatch (4 units packed RBCs, fresh frozen plasma, platelets, and cryoprecipitate), continuous FHR monitoring, and emergency delivery (cesarean birth unless rapid vaginal delivery is imminent and fetal status is stable).

Vasa Previa

Mechanism: Fetal vessels, unprotected by Wharton's jelly or placental parenchyma, traverse the membranes across the cervical os ahead of the fetal presenting part. When membranes rupture (spontaneously or via AROM), the vessels lacerate, resulting in rapid fetal exsanguination (the total blood volume of a term fetus is only ~250–300 mL).

Management: If diagnosed prenatally via color Doppler, elective cesarean is performed at 34 0/7 to 37 0/7 weeks . If acute rupture occurs, immediate emergent delivery within minutes is the sole chance of neonatal survival.

Amniotic Fluid Volume Disorders

Amniotic fluid volume reflects fetal renal perfusion, swallowing, lung fluid secretion, and placental membrane exchange. It is quantified via ultrasound using either the Amniotic Fluid Index (AFI) (sum of deepest vertical pockets in four quadrants) or the Single Deepest Vertical Pocket (DVP) .

Polyhydramnios

Diagnostic Thresholds: AFI ≥24 cm or DVP ≥8 cm .

Etiologies: Idiopathic (50%–60%), maternal diabetes (fetal osmotic diuresis), fetal gastrointestinal anomalies impairing swallowing (tracheoesophageal fistula, esophageal or duodenal atresia), fetal neuromuscular disorders (impaired swallowing), congenital infections (parvovirus, CMV), fetal hydrops, and twin-to-twin transfusion syndrome (recipient twin).

Clinical Complications: Maternal dyspnea, premature rupture of membranes, preterm labor, and abnormal fetal lie. Intrapartum risks include umbilical cord prolapse upon membrane rupture and placental abruption caused by rapid decompression of the overdistended uterus.

Oligohydramnios

Diagnostic Thresholds: AFI <5 cm or DVP <2 cm .

Etiologies: Rupture of membranes (most common), uteroplacental insufficiency (chronic hypertension, preeclampsia, systemic vascular disease, severe FGR), fetal genitourinary malformations (bilateral renal agenesis [Potter sequence], posterior urethral valves), post-term pregnancy (>41–42 weeks), and medications (ACE inhibitors, indomethacin).

Clinical Complications: Pulmonary hypoplasia (if present in early second trimester due to absence of fluid splinting alveoli), umbilical cord compression (manifesting as variable decelerations on FHR tracings), meconium aspiration syndrome, and intrauterine fetal death.

Loading diagram... Third-Trimester Vaginal Bleeding Triage Algorithm